Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information

The test substance was considered to be non-mutagenic with and without metabolic activation in bacteria (reference 7.6.1 -1).

Link to relevant study records
Reference
Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
07 February 2017 - 22 May 2017
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
1997
Deviations:
no
Qualifier:
according to guideline
Guideline:
JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
Version / remarks:
1993
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
Version / remarks:
2008
Deviations:
no
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Metabolic activation:
with and without
Metabolic activation system:
S9 mix induced by ß-Naphthoflavone/Phenobarbital in livers of rats
Test concentrations with justification for top dose:
1st serie: 5.0, 15.8, 50.0, 158, 500, 1580, 5000 µg/plate
2nd serie: 158, 500, 1580, 2810, 5000 µg/plate
top dose: maximum recommended concentration (according to OECD 471)
Vehicle / solvent:
- Vehicle/solvent used: ultrapure water
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
4-nitroquinoline-N-oxide
9-aminoacridine
sodium azide
other: 2-aminoanthracene, daunomycin
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation)

DURATION
- Exposure duration: 2 to 3 days

NUMBER OF REPLICATIONS: 3 replicates for test item concentrations and positive controls, 6 replicates for solvent controls

DETERMINATION OF CYTOTOXICITY
- Method: counting numbers of revertants

OTHER:
- S9 concentration: 1st serie: 10%; 2nd serie: 20%
Evaluation criteria:
A test material was to be defined as negative or non-mutagenic in this assay if
- The assay was to be considered valid, and
- "no" or "weak increases" occurred in the test series performed ("weak increases" randomly occur due to experimental variation)

For valid data, the test material was considered to be positive or mutagenic if:
- a dose dependent (over at least two test material concentrations) increase in the number of revertants was induced, the maximal effect was a "clear increase", and the effects were reproduced at similar concentration levels in the same test system, or
- "clear increases" occurred at least at one test material concentration, higher concentrations showed strong precipitation or cytotoxicity, and the effects were reproduced at the same concentration level in the same test system.
Statistics:
Not performed as not mandatory for this test system.
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
at 5000 µg/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
at 1580 µg/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
at 5000 µg/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
at 5000 µg/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
at 5000 µg/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: Test material precipitate was observed on the plates at the concentration 5000 µg/plate (1st serie) and at concentrations ≥ 2810 µg/plate (2nd serie) until the end of the experiment.

Table 1: Summary 1st series

Metabolic Activation

Test Material

Concentr. [µg/plate]

Revertants per plate (Mean ± SD)

TA 98

TA 100

TA 1535

TA 1537

WP2 uvrA

Without Activation

H2O

 

49 ± 15

120 ± 10

20 ± 4

6 ± 2

26 ± 7

 

Test item

5.00

44 ± 11

118 ± 7

29 ± 5

7 ± 2

20 ± 4

 

 

15.8

38 ± 7

131 ± 4

26 ± 11

7 ± 1

21 ± 2

 

 

50.0

42 ± 8

121 ± 17

22 ± 9

5 ± 4

32 ± 4

 

 

158

47 ± 4

126 ± 13

24 ± 6

8 ± 1

20 ± 5

 

 

500

44 ± 13

123 ± 12

20 ± 4

4 ± 2

26 ± 6

 

 

1580

36 ± 6

122 ± 17

22 ± 6

1 ± 0

25 ± 10

 

 

5000

16 ± 3E

82 ± 11E

12 ± 2E

0 ± 0E

7 ± 5E

 

 

 

 

 

 

 

 

 

DAUN

1.00

240 ± 12

 

 

 

 

 

NaN3

2.00

 

1539 ± 35

891 ± 31

 

 

 

9-AA

50.0

 

 

 

514 ± 45

 

 

NQO

2.00

 

 

 

 

114 ± 204

 

 

 

 

 

 

 

 

With Activation

H2O

 

47 ± 9

120 ± 9

17 ± 5

8 ± 1

41 ± 9

 

Test item

5.00

52 ± 7

124 ± 8

20 ± 7

7 ± 1

47 ± 10

 

 

15.8

41 ± 15

128 ± 9

24 ± 5

9 ± 9

46 ± 9

 

 

50.0

53 ± 5

115 ± 7

22 ± 1

5 ± 5

29 ± 3

 

 

158

41 ± 7

118 ± 15

19 ± 3

4 ± 3

30 ± 8

 

 

500

43 ± 10

110 ± 8

25 ± 5

6 ± 1

44 ± 4

 

 

1580

42 ± 10

113 ± 13

18 ± 3

9 ± 4

34 ± 7

 

 

5000

14 ± 4E

66 ± 2E

17 ± 4E

0 ± 0E

16 ± 1E

 

 

 

 

 

 

 

 

 

2-AA

2.00

840 ± 41

1280 ± 69

 

 

 

 

2-AA

5.00

 

 

230 ± 30

354 ± 19

 

 

2-AA

10.0

 

 

 

 

459 ± 34

NaN3: Sodium azide, 2-AA: 2-Aminoanthracene, 9-AA: 9-Aminoacridine, DAUN: Daunomycin, NQO: 4-NitroquinoIine-N-oxide,E: Precipitation until end of experiment

Table 2: Summary 2nd series

Metabolic Activation

Test Material

Concentr. [µg/plate]

Revertants per plate (Mean ± SD)

TA 98

TA 100

TA 1535

TA 1537

WP2 uvrA

Without Activation

H2O

 

37 ± 8

124 ± 14

31 ± 9

10 ± 4

36 ± 6

 

Test Item

158

38 ± 5

133 ± 10

37 ± 6

5 ± 2

34 ± 10

 

 

500

33 ± 7

131 ± 16

37 ± 6

12 ± 3

32 ± 3

 

 

1580

35 ± 1

117 ± 19

29 ± 14

9 ± 3

36 ± 8

 

 

2810

20 ± 5E

111 ± 10E

18 ± 9E

0 ± 0E

29 ± 3E

 

 

5000

16 ± 7E

51 ± 14E

15 ± 2E

1 ± 1E

18 ± 5E

 

 

 

 

 

 

 

 

 

DAUN

1.00

271 ± 62

 

 

 

 

 

NaN3

2.00

 

1606 ± 30

871 ± 26

 

 

 

9-AA

50.0

 

 

 

823 ± 155

 

 

NQO

2.00

 

 

 

 

1347 ± 30

 

 

 

 

 

 

 

 

With Activation

H2O

 

53 ± 9

117 ± 11

25 ± 4

10 ± 4

35 ± 11C

 

Test Item

158

40 ± 10

112 ± 19

22 ± 9

10 ± 4

37 ± 12

 

 

500

47 ± 9

113 ± 5

24 ± 7

12 ± 6

34 ± 6

 

 

1580

36 ± 11

102 ± 7

22 ± 2

9 ± 3

37 ± 7

 

 

2810

29 ± 6E

95 ± 23E

20 ± 1E

1 ± 1E

24 ± 4E

 

 

5000

0 ± 1E

47 ± 18E

14 ± 2E

1 ± 1E

16 ± 3E

 

 

 

 

 

 

 

 

 

2-AA

2.00

304 ± 14

467 ± 15

 

 

 

 

2-AA

5.00

 

 

148 ± 19

89 ± 7

 

 

2-AA

10.0

 

 

 

 

198 ± 14

NaN3: Sodium azide, 2-AA: 2-Aminoanthracene, 9-AA: 9-Aminoacridine, DAUN: Daunomycin, NQO: 4-NitroquinoIine-N-oxide,E: Precipitation until end of experiment, C: Contaminated

Table 3: Historical Data - Negative Controls

Strain

TA 98

TA 100

TA 1535

TA 1537

WP2 uvrA

S9 Mix

Without

With

Without

With

Without

With

Without

With

Without

With

Compound

Solvent

Solvent

Solvent

Solvent

Solvent

Solvent

Solvent

Solvent

Solvent

Solvent

Total Plates

402

410

397

413

270

282

276

287

385

398

Number of Values

78

79

77

80

45

47

46

48

74

76

Minimum

23

25

82

101

20

18

23

20

16

17

Maximum

45

59

138

157

34

40

36

43

39

48

Mean

34

40

110

126

27

26

28

30

30

36

Standard Deviation

5.2

7.0

11.7

11.9

3.2

3.9

3.5

4.4

4.9

5.9

Table 4: Historical Data - Positive Controls

Strain

TA 98

TA 100

TA 1535

TA 1537

WP2 uvrA

S9 Mix

Without

With

Without

With

Without

With

Without

With

Without

With

Compound

DAUN

2-AA

NaN3

2-AA

NaN3

2-AA

9-AA

2-AA

NQO

2-AA

Total Plates

201

205

199

207

135

141

138

144

193

199

Number of Values

79

79

77

80

45

47

46

48

74

76

Minimum

117

105

412

512

583

92

122

125

395

112

Maximum

887

1632

2075

3337

1847

390

2882

1103

2286

1313

Mean

352

529

1337

1262

900

200

1175

418

1613

347

Standard Deviation

146.3

296.1

316.8

435.4

193.4

64.2

564.2

201.3

438.7

192.4

Conclusions:
The test substance was considered to be non-mutagenic with and without metabolic activation in bacteria.
Executive summary:

The test item was examined for its mutagenic activity in two series of in vitro microbial assays employing Salmonella typhimurium TA 98, TA 100, TA 1535 and TA 1537, and Escherichia coli WP2 uvrA as indicator organisms.

The plate incorporation test with and without addition of liver S9 mix from phenobarbital/p-naphthoflavone-pretreated rats was used. In this study, two experimental series were performed. In the experiments with S9 mix, 10% and 20% S9 in the S9 mix were used.

Treatments of all tester strains were performed using test item formulations prepared in ultra-pure water in the absence and in the presence of S9 mix, using final concentrations between 5 and 5000 µg/plate, plus vehicle and positive controls.

The strain specific positive control test materials, namely daunomycin, sodium azide, 4-nitroquin-oline-N-oxide, and 9-aminoacridine in the absence of S9 mix, yielded the expected mutant frequencies that were greatly in excess of the negative controls. The genotype of the tester strains used was thus confirmed. 2-Aminoanthracene, which requires metabolic activation, was strongly mutagenic. This indicates that the exogenous metabolizing system used in the present investigation (S9 mix) was active.

Precipitation of the test material on the agar plates occurred at concentrations ≥ 2810 µg/plate. Toxicity to the bacteria (drop of revertant numbers) was observed beginning at 1580 µg/plate and in all strains at 5000 µg/plate. The individual and summarized data are presented in the tables section.

Under the conditions described, there were no relevant increases in revertant numbers observed after exposure to the test item in the absence and presence of S9 mix. Therefore, the test item was not mutagenic under the described experimental conditions.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Additional information

Bacterial Reverse Mutation Test

The test item was examined for its mutagenic activity in two series of in vitro microbial assays employing Salmonella typhimurium TA 98, TA 100, TA 1535 and TA 1537, and Escherichia coli WP2 uvrA as indicator organisms.

The plate incorporation test with and without addition of liver S9 mix from phenobarbital/p-naphthoflavone-pretreated rats was used. In this study, two experimental series were performed. In the experiments with S9 mix, 10% and 20% S9 in the S9 mix were used.

Treatments of all tester strains were performed using test item formulations prepared in ultra-pure water in the absence and in the presence of S9 mix, using final concentrations between 5 and 5000 µg/plate, plus vehicle and positive controls.

The strain specific positive control test materials, namely daunomycin, sodium azide, 4-nitroquin-oline-N-oxide, and 9-aminoacridine in the absence of S9 mix, yielded the expected mutant frequencies that were greatly in excess of the negative controls. The genotype of the tester strains used was thus confirmed. 2-Aminoanthracene, which requires metabolic activation, was strongly mutagenic. This indicates that the exogenous metabolizing system used in the present investigation (S9 mix) was active.

Precipitation of the test material on the agar plates occurred at concentrations ≥ 2810 µg/plate. Toxicity to the bacteria (drop of revertant numbers) was observed beginning at 1580 µg/plate and in all strains at 5000 µg/plate. The individual and summarized data are presented in the tables section.

Under the conditions described, there were no relevant increases in revertant numbers observed after exposure to the test item in the absence and presence of S9 mix. Therefore, the test item was not mutagenic under the described experimental conditions.

Justification for classification or non-classification

Classification, Labeling, and Packaging Regulation (EC) No 1272/2008

The available experimental test data are reliable and suitable for classification purposes under Regulation (EC) No 1272/2008. The results indicate that the substance is non-mutagenic. Based on available data on genetic toxicity, the test item is not classified according to Regulation (EC) No 1272/2008 (CLP), as amended for the tenth time in Regulation (EC) No 2017/776.